Medical Equipment

Virtual Biopsy Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

March 17, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Virtual Biopsy Market In 2026 And What Value Is Projected For 2030?

The virtual biopsy market has experienced rapid expansion in recent years. It is projected to increase from $0.71 billion in 2025 to $0.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.9%. The market’s past growth can be attributed to factors such as continued reliance on traditional biopsy procedures, limited imaging technology capabilities, the increasing prevalence of chronic diseases, the expansion of hospital and diagnostic infrastructure, and a rising demand for accurate cancer diagnostics.

The virtual biopsy market is poised for significant expansion in the coming years, with projections indicating a rise to $1.23 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 11.7%. This anticipated growth stems from several factors, including ongoing advancements in imaging algorithms and AI analytics, the broadening of diagnostic applications in oncology and neurology, greater uptake in treating cardiovascular and ophthalmological conditions, its incorporation into personalized medicine strategies, and increasing investments directed towards research institutions and diagnostic facilities. Key developments anticipated during this period encompass a wider acceptance of non-invasive diagnostic methods, a heightened need for early disease identification, the fusion of sophisticated imaging techniques with predictive analytics, an extension of virtual biopsy’s utility across various therapeutic fields, and an increased emphasis on patient well-being and faster recuperation.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp

What Drivers Are Influencing The Virtual Biopsy Market?

The increasing occurrence of cancer-related conditions is anticipated to boost the expansion of the virtual biopsy market in the future. Oncological disorders encompass various cancer types where atypical cells proliferate and disseminate throughout the body. The uptick in these disorders is largely attributable to evolving lifestyle habits, including inadequate nutrition, sedentary routines, smoking, and greater exposure to environmental contaminants. Virtual biopsy technology supports the diagnosis and oversight of oncological conditions by offering non-invasive, immediate imaging data, thereby decreasing the necessity for conventional tissue sampling while simultaneously elevating diagnostic precision and patient well-being. For example, in January 2023, a report from Rock Health, a U.S.-based digital health research firm, indicated a projection of 1,958,310 new cancer cases in the U.S. for 2023, representing an increase from approximately 1.9 million new cases recorded in 2022. Consequently, the growing incidence of oncological disorders is a key factor propelling the virtual biopsy market forward.

What Are The Key Segments Of The Virtual Biopsy Market?

The virtual biopsy market covered in this report is segmented –

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

What Key Trends Are Influencing The Development Of The Virtual Biopsy Market?

Major enterprises operating within the virtual biopsy market are concentrating on creating technologically sophisticated solutions and securing necessary approvals, such as for the magnetic resonance spectroscopy (MRS) platform. This effort aims to elevate non-invasive diagnostic precision and offer real-time analysis for the prompt identification of diseases and tailored therapeutic approaches. Magnetic resonance spectroscopy (MRS) serves as a non-invasive imaging method that supports virtual biopsy by supplying comprehensive molecular data about tissues, thereby facilitating accurate, real-time disease identification and ongoing monitoring without requiring intrusive procedures. For example, in November 2023, the U.S. Food and Drug Administration (FDA) granted approval to the artificial intelligence (AI)-driven BrainSpec platform, developed by BrainSpec Inc., a healthtech firm based in the US. This technology employs sophisticated artificial intelligence (AI) analysis of MR spectroscopy data to quantify brain metabolites, including 2-hydroxyglutarate, thereby enabling non-invasive virtual biopsies for diagnosing conditions such as gliomas, alzheimer’s, and multiple sclerosis. The system is designed to integrate smoothly with standard magnetic resonance imaging (MRI) scanners, automate data processing, and yield results in just minutes. Furthermore, it leverages a reference database of brain chemistry to enhance diagnostic accuracy.

Who Are The Leading Companies Operating In The Virtual Biopsy Market?

Major companies operating in the virtual biopsy market are Siemens Healthineers AG, GE Healthcare, Canon Medical Systems, Philips Healthcare, Fujifilm Healthcare, Esaote SpA, Samsung Medison, Perspectum Ltd, QUIBIM SL, ImageBiopsy Lab GmbH, Deep Bio Inc, BrainSpec Inc, Oncoustics Inc, AI Metrics LLC, Zebra Medical Vision, Arterys Inc, Aidoc Medical, Viz ai, Subtle Medical, Gleamer AI

Read the full virtual biopsy market report here:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Virtual Biopsy Market?

North America was the largest region in the virtual biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Virtual Biopsy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp

Browse Through More Reports Similar to the Global Virtual Biopsy Market 2026, By The Business Research Company

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795